Factor VIII Dosing Calculator

Calculates the factor VIII dose needed to reach a target plasma level in patients with hemophilia A.

kglbs
%
%

Indications for Use

Used for calculating pre‑operative cardiac risk in patients undergoing elective or time‑sensitive non‑cardiac surgery when estimated MACE risk may change peri‑operative management. Identifies patients with <1% vs ≥1% MACE risk to guide need for further testing or optimization 1 [Level I evidence].

Factor VIII dosing is indicated for treatment or prevention of bleeding in hemophilia A, guiding weight‑based replacement to achieve target FVIII activity levels in trauma, surgery, or spontaneous bleeding episodes.

Insights & Cautions

Start with weight‑based dose = weight(kg) × desired FVIII rise(%)/2, then adjust for individual recovery.

  • Avoid assuming recovery = 2; underweight and overweight patients show median recoveries of 1.60 and 2.70, respectively, requiring IBW‑based adjustments 1 [Level II evidence].
  • Use PK‑guided refinement when possible; extended‑half‑life products show wide half‑life variability (19–40 h) influencing dose needs 2 [Level I evidence]; 3 [Level I evidence].
  • Inhibitor risk rises with high‑intensity early dosing, so avoid unnecessary large boluses in PUPs 4 [Level II evidence].